{
  "id": "e093cc6c24c52630",
  "title": "STAT+: Novo Nordisk accuses Hims & Hers of \u2018illegal mass compounding\u2019 over a cheaper version of Wegovy pill",
  "description": "Hims &#38; Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk, prompting the drugmaker to accuse the telehealth platform of \u201cillegal&#8230;",
  "content": "Hims &#38; Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk, prompting the drugmaker to accuse the telehealth platform of \u201cillegal&#8230;",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/05/novo-weight-obesity-wegovy-hims-compounding-telehealth/?utm_campaign=rss",
  "published_at": "2026-02-05T20:51:10+00:00",
  "fetched_at": "2026-02-06T00:27:14.258190+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Novo Nordisk accuses Hims & Hers of \u2018illegal mass compounding\u2019 over a cheaper version of Wegovy pill",
    "description": "Hims &#38; Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk, prompting the drugmaker to accuse the telehealth platform of \u201cillegal&#8230;",
    "url": "https://www.statnews.com/pharmalot/2026/02/05/novo-weight-obesity-wegovy-hims-compounding-telehealth/?utm_campaign=rss",
    "published": "2026-02-05T20:51:10+00:00",
    "source": "STAT"
  }
}